Probably the most accurate and concise articles written are:
Review all the Articles and Blogs from our 2 Authors:
Zacks is providing "paid coverage". Various reports here from them:
Delays are never good, right? Here is the thing... The trial ends when the 298th event (death) happens. But people aren't dying as fast as statistics would suggest for survival of Head and Neck cancer patients. Why? We believe its Multikine. The most recent Corporate Presentation 10/25 noted that the 298 event hasn't occurred.
On 10/15/19, it was announced that the IDMC reviewed the UNBLINDED data for efficacy, safety and FUTILITY. Their recommendation: Continue the trail until the last event! Details HERE
Need more proof and you're a Stats Junkie? Then head on over to the Google Sheets created by our "National Treasure" FOSCO and team from the iHub message boards. These sheets estimate that we are now past 10% of Standard Care.
With much effort, our team has published the following articles on SeekingAlpha:
Visit these great Authors on SeekingAlpha for all the latest scoop on CVM. Be sure to read their Blogs too!
ALOS VISIT VFC'S STOCKHOUSE WEBSITE FOR GREAT WRITE-UPS ON CVM.
On 3/29/19, Cel-Sci released a PR stating that the IDMC has done their recent interim review and they made the following recommendation:
"continue the trial until the appropriate number of events have occurred."
More info on the IDMC on our IDMC page
This is a big fucking deal! At this point in the 8 year study, they have about 95% of all the data. They would know if the study was futile or not. If it was futile, they would have shut it down.
In the last 2 weeks the IDMC has shut down 3 trials for FUTILITY. CVM just had the IDMC review their Phase III study for futility and recommended the trial should continue. The 3 PRs link below are from the 3 recent trials that were just shut down:
REVERSE SPLITS is the latest SHORT tactic! Yes, we have had 3 Reverse Splits. But that was then due to low share price. Did you know a Reverse Split REQUIRES Shareholder approval? Its true. This approval request is done via a Proxy. Here is the latest Proxy:
****DID YOU SEE ANY REQUEST FOR AN APPROVAL OF A REVERSE SPLIT!?***
Furthermore, why would we do a Reverse Split now that we are at $5.00? Are we at threat to be delisted? No! Here is why companies do Reverse Splits:
This is always an issue with Biotechs. Constant financing. Dilution. Wash, Rinse, Repeat.
The last 10Q as of 6/30/19 stated they have over $12M of cash. No offering until April 2020!
Visit Cash Page for current details
Really? We currently have a $295M (as of 7/2/19) Market Cap and a share price over $8.00. Do some due diligence. Upon a successful read out of the Phase III data, we are talking Billions and Billions! I wont give you share price expectations, but what I will give you is recent buyouts of other bios:
Do the math! We are at $295M with about 33M shares outstanding....How does one get to a $5B-$10B. Market Cap...? The multiples are insane, but its possible!
Bashers Bash. See why here: https://messageboardfools.com/bashers.htm
They will say anything to make your give up your shares. Stay long!
Copyright © 2019 Killcvmshorts - All Rights Reserved. NOT AFFILIATED WITH CEL-SCI IN ANY CAPACITY! THIS WEBSITE SHOULD NOT BE CONSIDERED INVESTMENT ADVICE. WEBSITE CREATED BY A NUT JOB WITH TOO MUCH TIME ON HIS HANDS. THIS NUT JOB HAS SHARES OF CVM AND IS LONG. THIS NUT JOB ISNT BEING COMPENSATED FOR THIS SITE. THIS NUT JOB NEVER HAS BEEN COMPENSATED FOR ANY OF MY DUE DILIGENCE OR WORK RELATED TO CVM. ALL THESE OPINIONS ARE OF A NUT JOB.
Powered by GoDaddy Website Builder